0.3999
Femasys Inc stock is traded at $0.3999, with a volume of 3.64M.
It is up +12.62% in the last 24 hours and down -51.21% over the past month.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
See More
Previous Close:
$0.3551
Open:
$0.36
24h Volume:
3.64M
Relative Volume:
5.30
Market Cap:
$13.03M
Revenue:
$950.10K
Net Income/Loss:
$-16.69M
P/E Ratio:
-0.4818
EPS:
-0.83
Net Cash Flow:
$-15.16M
1W Performance:
+6.36%
1M Performance:
-51.21%
6M Performance:
-74.53%
1Y Performance:
-65.82%
Femasys Inc Stock (FEMY) Company Profile
Name
Femasys Inc
Sector
Industry
Phone
770-500-3910
Address
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
FEMY
Femasys Inc
|
0.3999 | 11.57M | 950.10K | -16.69M | -15.16M | -0.83 |
![]()
ISRG
Intuitive Surgical Inc
|
469.07 | 169.67B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
188.15 | 55.31B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
RMD
Resmed Inc
|
270.99 | 40.19B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
ALC
Alcon Inc
|
78.27 | 39.46B | 10.03B | 1.07B | 1.39B | 2.17 |
![]()
WST
West Pharmaceutical Services Inc
|
243.74 | 17.76B | 2.96B | 487.70M | 344.00M | 6.68 |
Femasys Inc Stock (FEMY) Latest News
Femasys Inc. shares fall 2.50% after-hours following $8 million financing closure. - AInvest
Key resistance and support levels for Femasys Inc.July 2025 Levels & Risk Managed Investment Signals - Newser
Is Femasys Inc. a potential multi baggerJuly 2025 Levels & Real-Time Market Sentiment Alerts - خودرو بانک
What data driven models say about Femasys Inc.’s future2025 Technical Overview & Stock Portfolio Risk Management - Newser
Femasys’ $8M Financing: A Strategic Inflection Point in Women's Health Innovation - AInvest
How to integrate Femasys Inc. into portfolio analysis toolsTrade Volume Report & Short-Term High Return Ideas - Newser
Applying sector rotation models to Femasys Inc.Treasury Yields & High Accuracy Investment Entry Signals - Newser
Femasys Secures $8M for Reproductive Health Innovations - AInvest
Femasys closes $8M in financing - MSN
Femasys closes $8 million in financing to accelerate commercialization of fertility and birth control portfolios - MarketScreener
Is Femasys Inc. stock suitable for long term investing2025 Key Highlights & Expert Approved Trade Ideas - خودرو بانک
Multi asset correlation models including Femasys Inc.Market Rally & Verified Short-Term Plans - Newser
Is it time to cut losses on Femasys Inc.Trade Exit Summary & Proven Capital Preservation Tips - Newser
Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios - The Manila Times
Femasys Closes $8 Million Financing for Women's Health Growth and Impact - AInvest
Non-Surgical Birth Control Pioneer Femasys Lands $8M to Scale Revolutionary Women's Health Solutions - Stock Titan
Forecasting Femasys Inc. price range with options dataTrade Entry Summary & Technical Pattern Alert System - Newser
Whale Trades: Will Femasys Inc. benefit from current market trendsJuly 2025 Update & Fast Gain Swing Trade Alerts - خودرو بانک
Will Femasys Inc. continue its uptrend2025 Key Highlights & AI Enhanced Trading Signals - Newser
What’s the beta of Femasys Inc. stockQuarterly Portfolio Report & Stock Market Timing Techniques - خودرو بانک
What does recent volatility data suggest for Femasys Inc.Gap Down & Community Driven Trade Alerts - Newser
Will Femasys Inc. benefit from current market trendsJuly 2025 Momentum & Consistent Return Strategy Ideas - خودرو بانک
What Fibonacci levels say about Femasys Inc. reboundLayoff News & Real-Time Volume Surge Alerts - Newser
Femasys Inc. Added to Custom Quant Screener Today2025 Sector Review & Community Verified Trade Alerts - beatles.ru
How to build a dashboard for Femasys Inc. stockJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - Newser
Femasys Inc. stock outlook for YEARWeekly Trend Report & Weekly Setup with ROI Potential - Newser
Smart tools for monitoring Femasys Inc.’s price actionWeekly Trading Summary & Stock Portfolio Risk Management - Newser
Ranking Femasys Inc. among high performing stocks via tools2025 Dividend Review & Breakout Confirmation Trade Signals - Newser
Using fundamentals and technicals on Femasys Inc.Market Sentiment Summary & Consistent Growth Equity Picks - Newser
Can swing trading help recover from Femasys Inc. lossesBreakout Watch & Risk Controlled Swing Trade Alerts - Newser
Does Femasys Inc. qualify in momentum factor screeningTrade Signal Summary & Real-Time Stock Price Movement Reports - Newser
Regression analysis insights on Femasys Inc. performancePortfolio Gains Report & Verified Short-Term Plans - Newser
Order flow analysis tools used on Femasys Inc.Quarterly Portfolio Summary & Reliable Intraday Trade Plans - Newser
Has Femasys Inc. formed a bullish divergenceJuly 2025 WrapUp & Precise Entry and Exit Recommendations - Newser
Published on: 2025-08-31 15:55:25 - Newser
Can momentum traders help lift Femasys Inc.2025 Top Decliners & Safe Swing Trade Setups - Newser
Tools to monitor Femasys Inc. recovery probability2025 Big Picture & Community Trade Idea Sharing Platform - Newser
Femasys Inc Stock (FEMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):